Promega corporation:1107424 - hdac-GLO(TM) I/II assay, 100ML for NIH/ncats staff menghang XIA/SRI sakamuru
Ended Awarded
- Contract number
- HHSN31900009
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,966
Award facts
- Contract value 100% obligated
- $24,966.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
Promega Corporation was awarded a $24,966.20 firm fixed price contract by the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health, for the supply of HDAC-GLO I/II Assay reagent kits (100 mL) to support research conducted by NIH/NCATS staff members Menghang Xia and Sri Sakamuru. The award was issued on February 18, 2016, with an ultimate completion date of February 29, 2016, and was executed as a call against Promega's existing Blanket Purchase Agreement with NIH. The place of performance is Promega's headquarters in Madison, Wisconsin. No small business set-aside designation was applied to this award, consistent with Promega's status as a large, for-profit life sciences manufacturer.
This contract represents a routine procurement of specialized research assay materials through an established indefinite delivery vehicle. HDAC-GLO assays are luciferase-based detection kits used in high-throughput screening applications to measure histone deacetylase activity, a critical tool for translational research at NCATS. The short performance period reflects the consumable nature of the reagent kits and the immediate research needs of the NIH laboratory staff. Promega's $10 million NIH BPA with the Office of Logistics and Acquisition Operations provides the contracting mechanism for such task orders involving biological materials, chemicals, and laboratory equipment across multiple NIH institutes and centers.
Quick answers
Who was awarded contract HHSN31900009?
HHSN31900009 was awarded to Promega Corporation by National Center for Advancing Translational Sciences (National Institutes of Health) on February 18, 2016.
How much is contract HHSN31900009 worth?
The government has obligated $24,966 on HHSN31900009.
Is contract HHSN31900009 an order under another contract?
Yes. HHSN31900009 is a BPA call under HHSN263201500038B, a blanket purchase agreement.
Was contract HHSN31900009 competed?
The extent of competition for HHSN31900009 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award